Skip to main content

News

Canadian maker of promising mRNA vaccine looks to test it against Pfizer in new trial
Calgary-based Providence Therapeutics says its vaccine produced no serious adverse events and developed good antibodies against COVID-19 that "compare favourably'' with the two mRNA vaccines already on the market from Pfizer and Moderna.
BC doctor finds reporting system for vaccine adverse events 'completely inscrutable and unusable'
A British Columbia physician who reviewed the forms used in each Canadian province to report adverse effects from COVID-19 vaccines found the country’s information-gathering process “completely inscrutable and unusable.”

Preliminary data from vaccine mixing study shows higher reactogenicity, no other safety concerns

Much anticipated research out of the U.K. on vaccine mixing has had encouraging preliminary results where safety is concerned.
Getting surplus COVID-19 vaccines in Detroit to Windsor is just a bridge too far

Cross-border vaccinations
Quebec coroner's inquest into death of Joyce Echaquan begins as her family testifies
Alberta healthcare workers hope to avoid triage protocol but situation remains tense
Ontario to get new AstraZeneca shipment, reserve doses for second shots
Meet the 2021 Pharmacy U Innovation Award winners
Mental health hospitalizations involving young people in Quebec rise during pandemic

Montreal–The number of Quebecers aged 12 to 17 admitted to hospital for mental health reasons following an emergency room visit increased 40% in January and February over the same period last year.
AstraZeneca pause major challenge for Ontario pharmacists, but they're ready for big mRNA rollout: Bates

These latest developments will likely raise questions in patients’ minds about when they can and should be getting their second doses.

X

This ad will auto-close in 10 seconds